Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VOR
Stock Latest News
The Fly
Vor Bio says telitacicept shows sustained efficacy in China Phase 3 study
14h ago
VOR
Premium
The Fly
Vor Bio price target adjusted to $55 at H.C. Wainwright after reverse split
17h ago
VOR
Premium
Company Announcements
Vor Biopharma Unveils Promising Phase 3 Trial Results
1d ago
8K
VOR
Premium
Weekend Updates
Major Moves: Fifth Third, HEICO, Transdigm, Cytokinetics, Vor Biopharma
5d ago
HEI
TDG
Premium
The Fly
Vor Bio announces Phase 3 study on telitacicept in SLE met primary endpoint
14d ago
VOR
Premium
The Fly
Vor Bio upgraded to Outperform from Neutral at Baird
15d ago
VOR
Premium
The Fly
Vor Bio, RemeGen announce Phase 3 study of telitacicept met primary endpoint
16d ago
VOR
Premium
The Fly
Largest borrow rate increases among liquid names
21d ago
BNC
VOR
Premium
The Fly
Largest borrow rate increases among liquid names
22d ago
CEP
FLY
Premium
The Fly
Largest borrow rate increases among liquid names
23d ago
SLI
VOR
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
AS
BNC
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
BNC
MBX
Premium
The Fly
Vor Bio files to sell 51M shares of common stock for holders
1M ago
VOR
Premium
The Fly
Vor Bio upgraded to Buy from Hold at Stifel
1M ago
VOR
Premium
Ratings
Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline
1M ago
VOR
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
VOR
AIRS
Premium
The Fly
Vor Bio appoints Khan as Chief Medical Affairs Officer
1M ago
VOR
ARGX
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
CNQ
IEP
Premium
The Fly
Vor Biopharma trading halted, news pending
1M ago
VOR
Premium
Company Announcements
Vor Biopharma Announces 1-for-20 Reverse Stock Split
1M ago
8K
VOR
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
BHP
MPW
Premium
Company Announcements
Vor Biopharma Focuses on Telitacicept Development Strategy
2M ago
8K
VOR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
